دورية أكاديمية

HPLC method development and validation for the estimation of Axitinib in rabbit plasma

التفاصيل البيبلوغرافية
العنوان: HPLC method development and validation for the estimation of Axitinib in rabbit plasma
المؤلفون: Suneetha, Achanta, Donepudi, Sharmila
المصدر: Brazilian Journal of Pharmaceutical Sciences. January 2017 53(3)
بيانات النشر: Universidade de São Paulo, Faculdade de Ciências Farmacêuticas, 2017.
سنة النشر: 2017
مصطلحات موضوعية: High performance liquid chromatography/method validation, Axitinib/determination, Axitinib/ kidney cancer treatment, Crizotinibe, Rabbit plasma, Tyrosine kinase inhibitor
الوصف: A rapid, sensitive, and accurate high performance liquid chromatography for the determination of Axitinib (AN) in rabbit plasma is developed using crizotinibe as an internal standard (IS). Axitinib is a tyrosine kinase inhibitor, used in the treatment of advanced kidney cancer, which works by slowing or stopping the growth of cancer cells. The chromatographic separation was performed on a Waters 2695, Kromosil (150 mm × 4.6 mm, 5 µm) column using a mobile phase containing buffer (pH 4.6) and acetonitrile in the ratio of 65:35 v/v with a flow rate of1 mL/min. The analyte and internal standard were extracted using liquid-liquid extraction with acetonitrile. The elution was detected by photo diode array detector at 320 nm.The total chromatographic runtime is 10.0 min with a retention time for Axitinib and IS of 5.685, and 3.606 min, respectively. The method was validated over a dynamic linear range of 0.002-0.2µg/mL for Axitinib with a correlation coefficient of r2 0.999.
نوع الوثيقة: article
وصف الملف: text/html
اللغة: English
تدمد: 1984-8250
DOI: 10.1590/s2175-97902017000300012
URL الوصول: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502017000300607
حقوق: info:eu-repo/semantics/openAccess
رقم الأكسشن: edssci.S1984.82502017000300607
قاعدة البيانات: SciELO
الوصف
تدمد:19848250
DOI:10.1590/s2175-97902017000300012